About Us

History

  • 2021 Memorabilia

    February  Levofloxacin Tablets 0.5g, Parecoxib Sodium for Injection 40mg Centralized Collection Winning the Bid

    April  Fasudil hydrochloride injection (consistency) was approved for production

    May  Ornithine aspartate injection and thymosin for injection (consistency) were approved for production

    June  Clopidogrel hydrogen sulfate tablets and sitagliptin phosphate tablets were approved for production

  • 2020 Memorabilia

    In March, Kesu, Yousu and Baianxin won the Guangdong High-tech Product Certificate;

    In July, Rivaroxaban tablets were approved for production;

    In August Recognized as "Guangdong Provincial Science and Technology Expert Workstation";

    In September, glimepiride tablets 1mg and one-time enhanced tracheal intubation were approved for production;

    October was listed in the 2020 Guangdong Awards Top 500 Provincial Manufacturing Enterprises;

    Participated in the 45th International Quality Management Group Competition in December, and the project "Improving the Fit of RB Tablets Dissolution Curve" won the Platinum Award.


  • 2019 Memorabilia

    In July, Thymosin for injection was approved for production;

    In September, parecoxib sodium for injection was approved for production;

    In October, Atosiban acetate injection was approved for production;

    In October, participated in the 44th International Quality Management Group Competition, and the subject "Improving the Dissolution of Y Products" won the gold award;

    October Won the titles of "Top 100 Industrial Enterprises in China's Chemical and Pharmaceutical Industry in Comprehensive Strength in 2019" and "2019 Innovative Excellent Enterprise Brand in China's Chemical and Pharmaceutical Industry"

    In November, it was listed among the top 500 manufacturing enterprises in Guangdong Province in 2019;

  • 2018 Memorabilia

    In March, it was rated as "Guangzhou Key Manufacturing Enterprise" and "Guangzhou Two High Schools and Four New Enterprises"; "Glimepiride Tablets" successfully passed the on-site inspection of consistency evaluation;

    In April, "Anyining® (Fasudil Hydrochloride Injection)" was successfully approved;

    In July, "Yousu® (glimepiride tablets)" was the first to pass the consistency evaluation;

    In September, the freeze-dried powder injection workshop passed the GMP re-certification;

    In October, in the publication of the international ICQCC results, one of Hairui Pharmaceutical's results "Reducing the content of impurities in F APIs" won the gold award;

    In November, it was rated as "Top 500 Manufacturing Enterprises in Guangdong Province in 2018";

    In December, it passed the certification of "National Academician and Expert Workstation"; the No. 1 workshop of small volume injection passed GMP certification;

  • 2017 Memorabilia

    In July, in the 38th National Pharmaceutical Industry Quality Management (QC) Group Results Publishing, 5 QC results won the first prize, of which 4 won the first prize in the group and 1 won the second in the group; in the same month, it was recognized as "Guangdong Province Enterprise Technology Center”;

    In October, in the publication of the international ICQCC results, one of Hairui Pharmaceutical's achievements "Establishing a Microbial Map of the Freeze-dried Powder Injection Workshop" won the gold award;

    In November, it was rated as "Top 500 Manufacturing Enterprises in Guangdong Province in 2017"; "Guangzhou Innovation Benchmarking 100 Enterprises";

    In December, the establishment of Guangdong Academician and Expert Enterprise Workstation was successfully continued.

  • 2016 Memorabilia

    January Guangzhou Hairui Pharmaceutical was recognized as "2015 Guangdong Innovative Enterprise";

    In January, "Zhengyuan Capsule" was recognized as "2015 Guangdong High-tech Product";

    In October, it was awarded the titles of "2016 Top 500 Manufacturing Enterprises in Guangdong Province" and "2016 Guangzhou Industry Leading Enterprises"

    In December, "Bai An Xin® (Amlodipine Benazepril Tablets (I))", "Kesu® (Irbesartan Capsules)" and "Yousu® (Glimepiride Tablets)" were identified as "2016 Guangdong High-tech Products"

  • 2015 Memorabilia

    In June, it was awarded the "Guangdong Province Contract-abiding and Credit-Reliable Enterprise" for four consecutive years;

    In October, the Guangzhou Hairui Pharmaceutical team won the Gold Award of the International Quality Management Group Conference (ICQCC);

    In November, Zhengyuan Capsule won the "China Excellent Patent Award" from the State Intellectual Property Office;

  • 2014 Memorabilia

    In January, won the title of "Guangdong Engineering Technology Research Center";

    In February, won the honorary title of "Guangzhou Cleaner Production Enterprise";

    In March, the exclusive traditional Chinese medicine product "Zhengyuan Capsule" was approved for marketing;

    April Won the title of "2013 Gazelle Enterprise in Guangzhou Development Zone".

  • 2013 Memorabilia

    In March, two products of "Bai An Xin" (Amlodipine Benazepril Tablets (I)) and "Yousu" (Glimepiride Tablets) were rated as "2012 Guangdong High-tech Products"

    In June, the freeze-dried powder injection workshop passed the new GMP certification

    In June, won the honorary title of "2012 Guangzhou Economic and Social Contribution Outstanding Private Enterprise"

    In July, at the 34th China Pharmaceutical Quality Management Association's QC Paper Presentation Conference, won 8 first prizes, 8 best publication awards, and 4 excellent paper awards

    In December, passed the "ISO10012 measurement management system" certification

  • 2012 Memorabilia

    In February, the solid preparation workshop passed the new national GMP certification;

    In March, the solid preparation workshop passed the EU GMP certification;

    In March, won the honorary title of "2011 Guangdong Province Contract-abiding and Credit-Reliable Enterprise";

    In May, "Bei Xue" (desloratadine citrate tablets) won the honorary title of "National Key New Product";

    In July, he won 8 first prizes, 8 best publication awards, and 3 excellent paper awards at the 33rd China Pharmaceutical Quality Management Association's QC Paper Presentation Conference;

  • 2011 Memorabilia

    In January, "Bei Xue" (desloratadine citrate tablets) was rated as "2010 Guangdong High-tech Product"

    In April, won the title of "Demonstration Enterprise of Drug Quality Integrity Construction" awarded by China Pharmaceutical Quality Management Association

    Passed "ISO/IEC17025" certification in May

    In July, at the 32nd QC Paper Publishing Conference held by the 32nd China Pharmaceutical Quality Management Association, won 7 first prizes and 5 best publication awards;

    In August, the national exclusive product "Bai An Xin" (Amlodipine Benazepril Tablets (I)) was approved for marketing

  • 2010 Memorabilia

    In March, "Bei Xue" (desloratadine citrate tablets) was rated as "Guangzhou Science and Technology Achievement"

    In June, at the 31st China Pharmaceutical Quality Management Association's QC paper presentation conference, won 6 first prizes and 5 best publication awards

    In October, won the honorary title of "Guangzhou Private Technology Enterprise"

  • 2009 Memorabilia

    In June, he won 3 first prizes, 2 second prizes, and 2 best publication awards at the 30th China Pharmaceutical Quality Management Association's QC paper presentation conference;

    In September, the exclusive product "Bei Xue" (desloratadine citrate tablets) was successfully launched through the certification of "ISO9001, ISO14001 and OHSAS18001"

    In December, won the title of "High-tech Enterprise in Guangdong Province"

  • 2008 Memorabilia

    In January, the solid preparation workshop and freeze-dried powder injection workshop were officially put into production

  • 2007 Memorabilia

    In September, five products including "Yousu" (glimepiride tablets) were approved for marketing

    Tablets, capsules, granules and lyophilized powder for injection passed GMP certification in December

  • 2006 Memorabilia

    January Obtained production license for tablets, capsules, granules, and freeze-dried powder injections

  • 2004 Memorabilia

    April Hairui Pharmaceutical was officially established and obtained the business license